These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 431391)

  • 1. [Cefamandel--in-vitro activity and pharmacokinetics].
    Simon C; Nixdorf F
    Med Welt; 1979 Apr; 30(14):527-30. PubMed ID: 431391
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro activity and clinical pharmacology of cefamandole in comparison to cephalothin.
    Simon VC; Malerczyk V; Nixdorf F
    J Antimicrob Chemother; 1978 Jan; 4(1):85-90. PubMed ID: 624694
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative in-vitro activity of cefamandole, cefoxitin, cefuroxime and cephalothin.
    Brorson JE; Norrby R
    Scand J Infect Dis Suppl; 1978; (13):88-93. PubMed ID: 278150
    [No Abstract]   [Full Text] [Related]  

  • 4. Update on drug therapy. IV. Parenteral cephalosporins.
    Dahl SL; Elenbaas J; Hamburger S
    J Am Med Womens Assoc (1972); 1980 Apr; 35(4):99-100, 107-8. PubMed ID: 6246160
    [No Abstract]   [Full Text] [Related]  

  • 5. The in vitro activity of cefamandole against 3312 bacterial isolates. A Norwegian multicentre study.
    Digranes A; Bjorvatn B
    NIPH Ann; 1980 Dec; 3(2):141-7. PubMed ID: 7219840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cooperative study of bacterial incidence and susceptibility to cefamandole and other antibiotics (author's transl)].
    de Vega JC; Pais JR; del Tánago AG
    Med Clin (Barc); 1980 May; 74(10):387-94. PubMed ID: 7412431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates.
    Jones RN; Fuchs PC; Barry AL; Gavan TL; Gerlach EH; Sommers HM
    Clin Ther; 1980; 3(Spec Issue):14-23. PubMed ID: 6446389
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinico-microbiologic bases for the use of new cephalosporins].
    De Bac C; Mascellino MT; Nuti M
    Minerva Med; 1982 Apr; 73(15):899-903. PubMed ID: 6979006
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation of agar-disc-diffusion tests with minimum inhibitory concentrations of cefonicid (SK&F 75073) and cephalothin.
    Grappel SF; Guarini JR; Actor P; Weisbach JA
    J Antibiot (Tokyo); 1980 Jan; 33(1):85-7. PubMed ID: 7372555
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro antibacterial activity of a new 1-oxa cephalosporin compound.
    Downs JT; Andriole VT
    Yale J Biol Med; 1980; 53(2):149-59. PubMed ID: 6446810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cefamandole: in vitro and in vivo activity].
    Martinetto P; Valtz A; Cavallo GP; Angeretti A
    G Batteriol Virol Immunol; 1979; 72(1-6):44-61. PubMed ID: 553842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro and in vivo antimicrobial activity of cefuroxime cefamandole and cephalexin on freshly isolated strains of Gram-positive and Gram-negative bacteria].
    Piccolomini R; Arpini A; Di Sipio L; Minelli G
    Boll Soc Ital Biol Sper; 1981 Jul; 57(13):1450-6. PubMed ID: 7284112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug therapy reviews: antimicrobial spectrum, pharmacology and therapeutic use of cefamandole and cefoxitin.
    Fraser DG
    Am J Hosp Pharm; 1979 Nov; 36(11):1503-8. PubMed ID: 391032
    [No Abstract]   [Full Text] [Related]  

  • 14. [The microbiologic activity of cephalothin, cephalexin, cephacetrile, cephradine, cephazolin and cephamandol].
    Knothe H; Lauer B
    Adv Clin Pharmacol; 1974; 8():80-8. PubMed ID: 4468733
    [No Abstract]   [Full Text] [Related]  

  • 15. The antimicrobial activity of cefamandole.
    Meyers BR
    Scand J Infect Dis Suppl; 1980; suppl 25():17-22. PubMed ID: 6937948
    [No Abstract]   [Full Text] [Related]  

  • 16. Interpretive criteria for cefamandole and cephalothin disk diffusion susceptibility tests.
    Barry AL; Schoenknecht FD; Shadomy S; Sherris JC; Thornsberry C; Washington JA; Kammer RB
    Antimicrob Agents Chemother; 1979 Jan; 15(1):140-1. PubMed ID: 106770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefamandole against Bacteroides fragilis.
    McAllister TA
    Scand J Infect Dis Suppl; 1980; suppl 25():32-6. PubMed ID: 6937949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of the "in vitro" sensitivity of cefoxitin and cephalosporins].
    Torres A; Aguirre M; Ales JM
    Rev Clin Esp; 1979 Nov; 155(4):249-52. PubMed ID: 542674
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pediatric experiences with cefamandole nafate].
    Perinotto G; Belloni CL; Robecchi GA; Fiorella G
    Clin Ter; 1981 Apr; 97(2):165-74. PubMed ID: 7237956
    [No Abstract]   [Full Text] [Related]  

  • 20. [Activity of new cephalosporins against polyresistant bacterial strains].
    De Toffoli A; Fantin B
    Minerva Med; 1983 Mar; 74(9-10):427-31. PubMed ID: 6300736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.